Literature DB >> 12832375

Genetic damage in oligozoospermic patients detected by fluorescence in-situ hybridization, inverse restriction site mutation assay, sperm chromatin structure assay and the Comet assay.

T E Schmid1, A Kamischke, H Bollwein, E Nieschlag, M H Brinkworth.   

Abstract

BACKGROUND: The possibility that oligozoospermic men may have elevated levels of genetic damage in their sperm is of particular concern as they could transmit defects to their offspring.
METHODS: Sperm samples were obtained from 12 infertile, oligozoospermic patients and 12 healthy normozoospermic volunteers. Fluorescence in-situ hybridization (FISH) was used to determine aneuploidy rates in sperm and inverse restriction site mutation (iRSM) assay to determine gene mutations; defective chromatin packaging was quantified by sperm chromatin structure assay (SCSA) and DNA strand breaks by the Comet assay.
RESULTS: FISH analysis showed a significant increase in gonosomal X,Y,18 (P < 0.01) disomy and diploid sperm with X,Y,18,18 (P < 0.05) in the infertility patients compared with the controls. A significant increase (P < 0.01) in disturbed sperm chromatin was found in the infertility patients compared with the control group using the SCSA assay. In the Comet assay, a significant increase (P < 0.01) in the tail moment was found in the infertility patients compared with the control group, indicating significantly high levels of DNA strand breaks. There was no significant increase in point mutations detected by iRSM assay.
CONCLUSIONS: The data indicate that infertile oligozoospermic men have an elevated level of XY aneuploidy and XY diploidy in the germ-line, as well as elevated levels of sperm chromatin disturbances and sperm DNA strand breaks. These data demonstrate that oligozoospermic infertility patients show several different types of genetic damage in their sperm. Thus, such men appear to have defects at a variety of levels of spermatogenesis and their infertility may not just be a result of the oligozoospermia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12832375     DOI: 10.1093/humrep/deg259

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  6 in total

1.  Human sperm sex chromosome disomy and sperm DNA damage assessed by the neutral comet assay.

Authors:  M E McAuliffe; P L Williams; S A Korrick; R Dadd; F Marchetti; S E Martenies; M J Perry
Journal:  Hum Reprod       Date:  2014-07-27       Impact factor: 6.918

2.  The ability of sperm selection techniques to remove single- or double-strand DNA damage.

Authors:  María Enciso; Miriam Iglesias; Isabel Galán; Jonás Sarasa; Antonio Gosálvez; Jaime Gosálvez
Journal:  Asian J Androl       Date:  2011-07-04       Impact factor: 3.285

3.  The association between sperm sex chromosome disomy and semen concentration, motility and morphology.

Authors:  M E McAuliffe; P L Williams; S A Korrick; R Dadd; M J Perry
Journal:  Hum Reprod       Date:  2012-08-14       Impact factor: 6.918

4.  Detection of aneuploidy rate for chromosomes X, Y and 8 by fluorescence in-situ hybridization in spermatozoa from patients with severe non-obstructive oligozoospermia.

Authors:  Soumaya Mougou-Zerelli; Sonia Brahem; Molka Kammoun; Mehdi Jerbi; Hatem Elghezal; Mounir Ajina; Ali Saad
Journal:  J Assist Reprod Genet       Date:  2011-08-19       Impact factor: 3.412

5.  Environmental exposure of the mouse germ line: DNA adducts in spermatozoa and formation of de novo mutations during spermatogenesis.

Authors:  Ann-Karin Olsen; Ashild Andreassen; Rajinder Singh; Richard Wiger; Nur Duale; Peter B Farmer; Gunnar Brunborg
Journal:  PLoS One       Date:  2010-06-28       Impact factor: 3.240

6.  Integrity of human sperm DNA assessed by the neutral comet assay and its relationship to semen parameters and clinical outcomes for the IVF-ET program.

Authors:  Hee-Jun Chi; Da-Yeon Chung; Soon-Young Choi; Jong-Hyun Kim; Gi-Young Kim; Jae-Seok Lee; Hee-Sun Lee; Myung-Hee Kim; Sung-Il Roh
Journal:  Clin Exp Reprod Med       Date:  2011-03-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.